Crinetics Director Sells 5,000 Shares With Stock Down 4%, but Here's What Matters More

A director of Crinetics Pharmaceuticals sold 5,000 shares for approximately $180,761 on March 12, 2026. The sale represented 23.47% of the director Coelho's direct common stock, reducing his direct holdings from 21,300 to 16,300 shares. The report is a routine insider transaction with limited likely impact on the stock.

Analysis

A director of Crinetics Pharmaceuticals sold 5,000 shares for approximately $180,761 on March 12, 2026. The sale represented 23.47% of the director Coelho's direct common stock, reducing his direct holdings from 21,300 to 16,300 shares. The report is a routine insider transaction with limited likely impact on the stock.